Evidence map›Paper›PMID 37068593›Full record

ArticleJournal of thrombosis and haemostasis : JTH2023

Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.

Chan Li, Awital Bar Barroeta, Szu Shen Wong, Hyo Jung Kim, Monika Pathak, Ingrid Dreveny, Joost C M Meijers, Jonas Emsley

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Crystal structure of coagulation factor XII N-terminal domains 1-5.Acta crystallographica. Section D, Structural biology · 2025
    Article
  4. Circulation research · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Kininogen debuts on apple (domain) disks.Journal of thrombosis and haemostasis : JTH · 2023
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Chan LiBiodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, UK.
Awital Bar BarroetaDepartment of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands.
Szu Shen WongSchool of Pharmacy and Bioengineering, Keele University, Staffordshire, UK.
Hyo Jung KimBiodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, UK.
Monika PathakBiodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, UK.
Ingrid DrevenyBiodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, UK.
Joost C M MeijersDepartment of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands; Amsterdam UMC, University of Amsterdam, department of Experimental Vascular Medicine, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, The Netherlands.
Jonas EmsleyBiodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, UK. Electronic address: jonas.emsley@nottingham.ac.uk.
University of Nottingham · GBAmsterdam University Medical Centers · NLKeele University · GBSanquin · NL

Funding

British Heart Foundation RG/12/9/29775
6 · The paper itself

Abstract

backgroundHigh-molecular weight kininogen (HK) circulates in plasma as a complex with zymogen prekallikrein (PK). HK is both a substrate and a cofactor for activated plasma kallikrein, and the principal exosite interactions occur between PK N-terminal apple domains and the C-terminal D6 domain of HK.

objectivesTo determine the structure of the complex formed between PK apple domains and an HKD6 fragment and compare this with the coagulation factor XI (FXI)-HK complex.

methodsWe produced recombinant FXI and PK heavy chains (HCs) spanning all 4 apple domains. We cocrystallized PKHC (and subsequently FXIHC) with a 31-amino acid synthetic peptide spanning HK residues Ser565-Lys595 and determined the crystal structure. We also analyzed the full-length FXI-HK complex in solution using hydrogen deuterium exchange mass spectrometry.

resultsThe 2.3Å PKHC-HK peptide crystal structure revealed that the HKD6 sequence WIPDIQ (Trp569-Gln574) binds to the apple 1 domain and HK FNPISDFPDT (Phe582-Thr591) binds to the apple 2 domain with a flexible intervening sequence resulting in a bent double conformation. A second 3.2Å FXIHC-HK peptide crystal structure revealed a similar interaction with the apple 2 domain but an alternate, straightened conformation of the HK peptide where residues LSFN (Leu579-Asn583) interacts with a unique pocket formed between the apple 2 and 3 domains. HDX-MS of full length FXI-HK complex in solution confirmed interactions with both apple 2 and apple 3.

conclusionsThe alternate conformations and exosite binding of the HKD6 peptide likely reflects the diverging relationship of HK to the functions of PK and FXI.

Indexed as

Factor XIKininogen, High-Molecular-WeightBinding SitesHumansKininogensMolecular WeightPeptidesPrekallikreinFactor XIKininogen, High-Molecular-WeightKininogensPeptidesPrekallikreinfactor IXfactor XIfactor XIIkininogensprekallikrein

Identifiers

PMID37068593
OpenAlexW4365812753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.